Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: out_of_the_loop who wrote (1927)	7/11/1999 8:36:00 PM
From: Bill Wexler	Read Replies (2) \| Respond to of 10293

<<A three-phase study would be ridiculous>> I'm sure that GUMM stock promoters wouldn't want a real scientific analysis of Ziscam either since it would completely expose their fraud. Ziscam is implying that it cures the common cold. Compare the language on Zicam's web site (www.zicam.com) to the product description of a legitimate over the counter cold medication such as Robitussin. Since Zicam is making this fraudulent claim, I see no reason why it shouldn't be open to a three-phase clinical trial.